| Sector |
Healthcare
|
Compare with Sector peers |
| Industry |
Pharmaceuticals & Drugs
|
Compare with Industry peers |
| Website | http://www.norrispharma.com | |
| Market Cap | 11.75 Cr. | |
| Enterprise Value(EV) | 33.15 Cr. | 2023-03 |
| Financial Indicators | ||
|---|---|---|
| Earnings per share (EPS) | -1.92 | Trailing Twelve Months Ending 2023-06 |
| Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2023-06 |
| Industry PE | 37.43 | Trailing Twelve Months Ending 2023-06 |
| Book Value / Share | -12.98 | Trailing Twelve Months Ending 2023-06 |
| Price to Book Value | -0.91 | Calculated using Price: 11.75 |
| Dividend Yield | 0.00 | Period Ending 2022-03 |
| No. of Shares Subscribed | 1.00 Cr. | 10,000,700 Shares |
| FaceValue | 10 | |
| About Norris Medicines Ltd. | ||
| The business area of the company is manufacturing of Injections and Medicinal formulations. | ||
| 1 Day |
|
+3.89% |
| 1 Week |
|
+1.73% |
| 1 Month |
|
+2.00% |
| 3 Month |
|
+2.17% |
| 6 Month |
|
+10.33% |
| 1 Year |
|
-20.77% |
| 2 Year |
|
+27.58% |
| 5 Year |
|
+105.78% |
| 10 Year |
|
| 9 years | 2014-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
| Return on Equity (%) | -20.54 | -17.93 | 0.71 | -15.52 | -76.01 | -138.44 | ||||
| Return on Capital Employed (%) | -14.70 | 3.99 | 4.06 | -4.06 | -17.04 | -9.18 | -18.63 | -17.87 | -6.59 | |
| Return on Assets (%) | -7.17 | -5.80 | 0.23 | -4.18 | -13.07 | -9.37 | -16.48 | -29.19 | -21.99 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-03* Rs. Cr. |
| Shh. Funds | 6 | 5 | 5 | 5 | 2 | 0 | -2 | -7 | -11 | -12 | |
| Non Curr. Liab. | 5 | 6 | 6 | 6 | 5 | 8 | 11 | 13 | 16 | 18 | |
| Curr. Liab. | 8 | 5 | 5 | 10 | 11 | 9 | 8 | 12 | 7 | 8 | |
| Minority Int. | |||||||||||
| Equity & Liab. | 19 | 17 | 17 | 20 | 18 | 18 | 17 | 17 | 13 | 14 | |
| Non Curr. Assets | 10 | 10 | 10 | 11 | 11 | 10 | 9 | 9 | 8 | 9 | |
| Curr. Assets | 9 | 7 | 7 | 9 | 8 | 7 | 7 | 8 | 4 | 5 | |
| Misc. Exp. not W/O | |||||||||||
| Total Assets | 19 | 17 | 17 | 20 | 18 | 18 | 17 | 17 | 13 | 14 |
| Particulars | 10 years | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2023-06 Rs. Cr. TTM |
| Net Sales | 21 | 19 | 19 | 20 | 14 | 16 | 8 | 12 | 9 | 8 | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |
| Total Income | 21 | 19 | 19 | 21 | 14 | 16 | 8 | 12 | 9 | 8 | |
| Total Expenditure | -22 | -17 | -18 | -21 | -15 | -17 | -10 | -14 | -10 | -8 | |
| PBIDT | -1 | 2 | 1 | 0 | -2 | -1 | -2 | -2 | 0 | 1 | |
| Interest | 0 | -1 | -1 | -1 | -1 | -1 | -1 | -2 | -1 | -1 | |
| Depreciation | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | -1 | |
| Taxation | 1 | -1 | 0 | 0 | 1 | 0 | 1 | -1 | -1 | -1 | |
| Exceptional Items | |||||||||||
| PAT | -1 | -1 | 0 | -1 | -3 | -2 | -3 | -5 | -3 | -2 | |
| Adjusted EPS | -1 | -1 | 0 | -1 | -3 | -2 | -3 | -5 | -3 | -2 |
| Particulars | 10 years | 2013-03 Rs. Cr. | 2014-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
| Cash Fr. Operatn. | -1 | 1 | 1 | 1 | -1 | 1 | -2 | -3 | 1 | -1 | |
| Cash Fr. Inv. | -1 | -2 | -1 | 0 | -2 | 0 | 0 | 0 | 0 | ||
| Cash Fr. Finan. | 2 | 0 | 0 | -1 | 3 | -1 | 2 | 3 | -1 | 1 | |
| Net Change | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||
| Cash & Cash Eqvt | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
|
Thu, 10 Aug 2023
Results - Financial Results For June 30 2023 Results - Financial Results for June 30 2023 |
|
Thu, 03 Aug 2023
Board Meeting Intimation for June Quarter Results NORRIS MEDICINES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2023 inter alia to consider and approve 1. To consider and take on record the Un-Audited Financial Results of the Company for quarter ended 30th June 2023.2. Any other business with the permission of the Chair. |
|
Fri, 21 Jul 2023
Uploading Of Statement Of Investor Complaints Report For Period Ended June 30 2023 Through PDF Mode As There Is An Error While Uploading XBRL File On The Portal Uploading of Statement of Investor Complaints Report for period ended June 30 2023 through PDF Mode as there is an error while uploading XBRL file on the portal. A screenshot of the error is also enclosed herewith. |
| Mon, 25 Sep 2023 |
High Delivery Percentage
|
Opening at High
|
Closing Near 100 SMA
|
Closing Near 20 SMA
|
Close Crossing 20 SMA From Below
|
Equities
M.F.
Sectors
StockEdge Social